DocDollars

Deciphera Pharmaceuticals Inc.

MA · United States · Reporting entity ID 100000776815

Total reported 2019–2025
$134.8M
#75 of 2,960 reporting companies — 0.2% of all reported industry payments
$2.66M in general payments across 12,996 records, plus $132.1M in research funding across 24,288 records.

How it breaks down

General payments $2,655,099
Research funding $132,105,235

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Deciphera Pharmaceuticals Inc. reported $134.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #75 of 2,960 reporting companies. 98% of that was research funding and 2% general payments such as consulting, speaking, food and travel. 12,996 general payment records and 24,288 research records were filed.

Common questions about Deciphera Pharmaceuticals Inc.

How much has Deciphera Pharmaceuticals Inc. paid US doctors?

Deciphera Pharmaceuticals Inc. reported $134,760,334 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,655,099 in general payments, $132,105,235 in research funding.

How does Deciphera Pharmaceuticals Inc. rank among drug and device companies?

It ranks #75 of 2,960 reporting entities by total reported value, about 0.2% of all industry payments in the dataset.

Does a payment from Deciphera Pharmaceuticals Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.